Anastrazole

Anastrozole is a non-steroidal aromatase inhibitor extensively used in research focusing on estrogen-dependent pathologies. By competitively inhibiting the aromatase enzyme, anastrozole reduces systemic estrogen levels, providing a powerful tool for investigating hormone-sensitive cancers and endocrine disorders. Anastrozole’s pharmacokinetic profile is characterized by excellent oral bioavailability and a half-life conducive to once-daily dosing in research models. It has gained additional interest for studying estrogen modulation in male hypogonadism and other non-oncologic conditions. Anastrozole’s high specificity and tolerability profile have made it indispensable for experimental studies targeting estrogen pathways.
This product is intended solely for laboratory research use and is not approved for human or veterinary applications, diagnostic procedures, therapeutic uses, or consumption. All products are sold under the condition that they will be handled exclusively by qualified individuals familiar with their use and potential risks. Any application of this material in humans or animals for therapeutic or diagnostic purposes must comply with the regulations established in 21 CFR 312 and 21 CFR 600.